Evidence map›Paper›PMID 35604360›Full record

ArticleHuman molecular genetics2022

SEMA6B variants cause intellectual disability and alter dendritic spine density and axon guidance.

Amélie Cordovado, Martina Schaettin, Médéric Jeanne, Veranika Panasenkava, Anne-Sophie Denommé-Pichon, Boris Keren, Cyril Mignot, Martine Doco-Fenzy, Lance Rodan, Keri Ramsey and 38 more

Open access · greenAbstract read
In one paragraph

Article in Human molecular genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Variability in Neural Circuit Formation.Cold Spring Harbor perspectives in biology · 2024
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors at 20 institutions in 6 countries.

Amélie CordovadoUMR 1253, iBrain, University of Tours, INSERM, Tours 37032, France.ORCID 0000-0003-3125-556X
Martina SchaettinDepartment of Molecular Life Sciences, Neuroscience Center Zurich, University of Zurich, Zurich 8057, Switzerland.
Médéric JeanneUMR 1253, iBrain, University of Tours, INSERM, Tours 37032, France.
Veranika PanasenkavaUMR 1253, iBrain, University of Tours, INSERM, Tours 37032, France.
Anne-Sophie Denommé-PichonFunctional Unit in Innovative Genomic Diagnosis of Rare Diseases, FHU-TRANSLAD, Dijon-Bourgogne University Hospital, Dijon 21079, France.ORCID 0000-0002-8986-8222
Boris KerenGenetics Department, Pitié-Salpêtrière Hospital, AP-HP. Sorbonne University, Paris 75651, France.
Cyril MignotGenetics Department, Pitié-Salpêtrière Hospital, AP-HP. Sorbonne University, Paris 75651, France.
Martine Doco-FenzyUniversity Hospital Reims, AMH2, Genetics Division, SFR CAP santé EA3801, Reims 51100, France.
Lance RodanDivision of Genetics and Genomics, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.
Keri RamseyCenter for Rare Childhood Disorders, Translational Genomics Research Institute, Phoenix, AZ 85012, USA.
Vinodh NarayananCenter for Rare Childhood Disorders, Translational Genomics Research Institute, Phoenix, AZ 85012, USA.
Julie R JonesMolecular Diagnostic Laboratory, Greenwood Genetic Center, Greenwood, SC 29646, USA.
Eloise J PrijolesGreenwood Genetic Center, Greenwood, SC 29646, USA.
Wendy G MitchellNeurology Division, Keck School of Medicine, University of Southern California, Children's Hospital Los Angeles, CA 90027, USA.
Jillian R OzmoreDartmouth Hitchcock Medical Center, Lebanon, NH 03766, USA.
Kali JulietteNeurology Department, Gillette Children's Specialty Healthcare, St Paul, MN 55101, USA.
Erin TortiGeneDx, Gaithersburg, MD 20877, USA.
Elizabeth A NormandGeneDx, Gaithersburg, MD 20877, USA.
Leslie GrangerGenetics Division, Department of Pediatric Development and Rehabilitation, Randall Children's Hospital, Portland, OR 97227, USA.
Andrea K PetersenGenetics Division, Department of Pediatric Development and Rehabilitation, Randall Children's Hospital, Portland, OR 97227, USA.
Margaret G AuDepartment of Genetics and Metabolism, University of Kentucky, Lexington, KY 40536, USA.
Juliann P MathenyDepartment of Genetics and Metabolism, University of Kentucky, Lexington, KY 40536, USA.
Chanika PhornphutkulDivision of Human Genetics, Department of Pediatrics, Warren Alpert Medical School of Brown University, Hasbro Children's Hospital, Providence, RI 02903, USA.
Mary-Kathryn ChambersDivision of Genetics, Rhode Island Hospital, Hasbro Children's Hospital, Providence, RI 02903, USA.
Joaquín-Alejandro Fernández-RamosPediatric Neurology Unit, Department of Pediatrics, University Hospital Reina Sofía, IMIBIC and CIBERER, Córdoba 14004, Spain.
Eduardo López-LasoPediatric Neurology Unit, Department of Pediatrics, University Hospital Reina Sofía, IMIBIC and CIBERER, Córdoba 14004, Spain.
Michael C KruerPediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
Somayeh BakhtiariPediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
Marcella ZollinoUniversità Cattolica Sacro Cuore, Dipartimento Scienze della Vita e Sanità Pubblica, Sezione di Medicina Genomica, Roma 00168, Italy.
Manuela MorleoTelethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples 80078, Italy.
Giuseppe MarangiUniversità Cattolica Sacro Cuore, Dipartimento Scienze della Vita e Sanità Pubblica, Sezione di Medicina Genomica, Roma 00168, Italy.
Davide MeiPediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Meyer Children's Hospital, Member of ERN Epicare, University of Florence, Florence 50139, Italy.
Tiziana PisanoPediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Meyer Children's Hospital, Member of ERN Epicare, University of Florence, Florence 50139, Italy.
Renzo GuerriniPediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Meyer Children's Hospital, Member of ERN Epicare, University of Florence, Florence 50139, Italy.
Raymond J LouieMolecular Diagnostic Laboratory, Greenwood Genetic Center, Greenwood, SC 29646, USA.
Anna ChildersMolecular Diagnostic Laboratory, Greenwood Genetic Center, Greenwood, SC 29646, USA.
David B EvermanMolecular Diagnostic Laboratory, Greenwood Genetic Center, Greenwood, SC 29646, USA.
Betrand IsidorMedical Genetics Service, Clinical Genetics Unit, University Hospital of Nantes, Hôtel Dieu, Nantes 44093, France.
Séverine Audebert-BellangerClinical Genetics Service, University Hospital of Brest, Morvan Hospital, Brest 29609, France.
Sylvie OdentClinical Genetics Service, University Hospital, Genetic and Development Institute of Rennes IGDR, UMR 6290 University of Rennes, ITHACA ERN, Rennes 35203, France.
Dominique BonneauDepartment of Medical Genetics, University Hospital of Angers and Mitovasc INSERM 1083, CNRS 6015, Angers 49000, France.
Brigitte Gilbert-DussardierMedical Genetics, University Hospital, La Milétrie, BP 577, Poitiers 86021, France.
Richard RedonINSERM, CNRS, UNIV Nantes, Thorax Institute, Nantes 44007, France.
Stéphane BézieauINSERM, CNRS, UNIV Nantes, Thorax Institute, Nantes 44007, France.
Frédéric LaumonnierUMR 1253, iBrain, University of Tours, INSERM, Tours 37032, France.
Esther T StoeckliDepartment of Molecular Life Sciences, Neuroscience Center Zurich, University of Zurich, Zurich 8057, Switzerland.
Annick ToutainUMR 1253, iBrain, University of Tours, INSERM, Tours 37032, France.ORCID 0000-0002-5999-5300
Marie-Laure VuillaumeUMR 1253, iBrain, University of Tours, INSERM, Tours 37032, France.
Université de Tours · FRGreenwood Genetic Center · USCentre National de la Recherche Scientifique · FRMeyer Children's Hospital · ITBarrow Neurological Institute · USGenVec · USInstituto Maimónides de Investigación Biomédica de Córdoba · ESRandall Children's Hospital at Legacy Emanuel · USSorbonne Université · FRTranslational Genomics Research Institute · USUniversità Cattolica del Sacro Cuore · ITUniversity of Kentucky · USUniversity of Zurich · CHBoston Children's Hospital · USCentre Hospitalier Régional Universitaire de Brest · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire de Reims · FRDartmouth–Hitchcock Medical Center · USGillette Children's Specialty Healthcare · USInserm · FR

Funding

Genomic Insights into the Neurobiology of Cerebral PalsyR01NS106298 · NINDS · UNIVERSITY OF ARIZONA · PI KRUER, MICHAEL C · 2019 to 2023
$3.7M
NINDS NIH HHS R01 NS106298
6 · The paper itself

Abstract

Intellectual disability (ID) is a neurodevelopmental disorder frequently caused by monogenic defects. In this study, we collected 14 SEMA6B heterozygous variants in 16 unrelated patients referred for ID to different centers. Whereas, until now, SEMA6B variants have mainly been reported in patients with progressive myoclonic epilepsy, our study indicates that the clinical spectrum is wider and also includes non-syndromic ID without epilepsy or myoclonus. To assess the pathogenicity of these variants, selected mutated forms of Sema6b were overexpressed in Human Embryonic Kidney 293T (HEK293T) cells and in primary neuronal cultures. shRNAs targeting Sema6b were also used in neuronal cultures to measure the impact of the decreased Sema6b expression on morphogenesis and synaptogenesis. The overexpression of some variants leads to a subcellular mislocalization of SEMA6B protein in HEK293T cells and to a reduced spine density owing to loss of mature spines in neuronal cultures. Sema6b knockdown also impairs spine density and spine maturation. In addition, we conducted in vivo rescue experiments in chicken embryos with the selected mutated forms of Sema6b expressed in commissural neurons after knockdown of endogenous SEMA6B. We observed that expression of these variants in commissural neurons fails to rescue the normal axon pathway. In conclusion, identification of SEMA6B variants in patients presenting with an overlapping phenotype with ID and functional studies highlight the important role of SEMA6B in neuronal development, notably in spine formation and maturation and in axon guidance. This study adds SEMA6B to the list of ID-related genes.

Indexed as

EpilepsyIntellectual DisabilitySemaphorinsAnimalsAxon GuidanceChick EmbryoDendritic SpinesHEK293 CellsHumansSEMA6B protein, humanSemaphorins

Identifiers

PMID35604360
PMCPMC9764436
OpenAlexW4281392733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.